Silvia Novello

Ospedale San Luigi Gonzaga, University of Turin

Papers

2

Total Citations

46

H-Index

2

About

Silvia Novello is a leading figure in thoracic oncology, with her research centered on the clinical management of lung cancer, early-stage disease, and epidemiological trends. Her major contributions include a comprehensive analysis of lung cancer patterns in Italy, which provided critical insights into regional disparities and risk factors, and a landmark review of progress in early-stage lung cancer over four decades, highlighting advances in screening, surgery, and adjuvant therapies. Her most-cited works—"Lung Cancer in Italy" (2019, 24 citations) and "Early Stage Lung Cancer: Progress in the Last 40 Years" (2014, 22 citations)—underscore her influence in shaping both national and international treatment paradigms. Notably, she has been instrumental in integrating personalized medicine into clinical practice, advocating for biomarker-driven therapies, and improving outcomes for patients with non-small cell lung cancer. Her work bridges epidemiology and translational research, making her a key voice in the fight against one of the deadliest cancers worldwide.

Research Focus

Key Achievements

2
H-Index
2
Papers
46
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Lung Cancer in Italy
24 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Ospedale San Luigi Gonzaga, University of Turin

Top Papers

  1. 1
    Lung Cancer in Italy
    24 citations · 2019
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago